Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1991 Jul;32(1):1–2. doi: 10.1111/j.1365-2125.1991.tb05604.x

Should we cross off the crossover?

P Armitage
PMCID: PMC1368484  PMID: 1888627

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berry D. A. Subgroup analyses. Biometrics. 1990 Dec;46(4):1227–1230. [PubMed] [Google Scholar]
  2. Freeman P. R. The performance of the two-stage analysis of two-treatment, two-period crossover trials. Stat Med. 1989 Dec;8(12):1421–1432. doi: 10.1002/sim.4780081202. [DOI] [PubMed] [Google Scholar]
  3. GRIZZLE J. E. THE TWO-PERIOD CHANGE-OVER DESIGN AN ITS USE IN CLINICAL TRIALS. Biometrics. 1965 Jun;21:467–480. [PubMed] [Google Scholar]
  4. Hills M., Armitage P. The two-period cross-over clinical trial. Br J Clin Pharmacol. 1979 Jul;8(1):7–20. doi: 10.1111/j.1365-2125.1979.tb05903.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Senn S. J. Cross-over trials, carry-over effects and the art of self-delusion. Stat Med. 1988 Oct;7(10):1099–1101. doi: 10.1002/sim.4780071010. [DOI] [PubMed] [Google Scholar]
  6. Senn S. J. Problems with the two stage analysis of crossover trials. Br J Clin Pharmacol. 1991 Jul;32(1):133–133. doi: 10.1111/j.1365-2125.1991.tb05627.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Sheldon T. A. A graphical presentation of the results of crossover trials. Br J Clin Pharmacol. 1990 Sep;30(3):345–349. doi: 10.1111/j.1365-2125.1990.tb03782.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES